Docetaxel Distribution Following Intraperitoneal Administration in Mice
Purpose: Intraperitoneal (IP) chemotherapy with high molecular weight lipophilic antineoplastic agents such as the taxanes has shown promise in clinical trial evaluation for treatment of localized peritoneal cancers. We have previously developed an IP injectable hydrogel formulation (PoLigel) for su...
Saved in:
Main Authors: | Payam Zahedi (Author), Raquel De Souza (Author), Micheline Piquette-Miller (Author), Christine Allen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of PXR Genotype and Transporter Expression in the Placental Transport of Lopinavir in Mice
by: Sarabjit S. Gahir, et al.
Published: (2017) -
Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration
by: Sounak Bagchi, et al.
Published: (2023) -
mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis
by: Yumei Zhang, et al.
Published: (2022) -
STAT3 is involved in IL-6-Mediated Downregulation of Hepatic Transporters in Mice
by: Walaa Ali Abualsunun, et al.
Published: (2018) -
Effect of intranasal and intraperitoneal administration of peptides Semax and Noopept on the behavior of BALB/c mice
by: E. V. Vasilieva, et al.
Published: (2016)